TRICYCLIC HETEROAROMATIC COMPOUNDS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
申请人:Cox Jason M.
公开号:US20100056550A1
公开(公告)日:2010-03-04
The present invention is directed to novel substituted tricyclic heteroaromatic compounds of structural formula (I) which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
[EN] TRICYCLIC HETEROAROMATIC COMPOUNDS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES<br/>[FR] COMPOSÉS HÉTÉROAROMATIQUES TRICYCLIQUES EN TANT QU'INHIBITEURS DE LA DIPEPTIDYLE PEPTIDASE-IV POUR LE TRAITEMENT OU LA PRÉVENTION DE DIABÈTES
申请人:MERCK & CO INC
公开号:WO2008060488A1
公开(公告)日:2008-05-22
[EN] The present invention is directed to novel substituted tricyclic heteroaromatic compounds of structural formula (I) which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved. [FR] L'invention concerne de nouveaux composés hétéroaromatiques tricycliques substitués ayant la formule structurale I qui sont des inhibiteurs de l'enzyme dipeptidyle peptidase-IV et qui sont utiles dans le traitement ou la prévention de maladies dans lesquelles l'enzyme dipeptidyle peptidase-IV est impliquée, telles que les diabètes et en particulier les diabètes de type 2. L'invention concerne également des compositions pharmaceutiques comprenant ces composés et l'utilisation de ces composés et compositions dans la prévention ou le traitement de telles maladies dans lesquelles l'enzyme dipeptidyle peptidase-IV est impliquée.